Pediatric thrombosis: application of dalteparin for treatment and prevention
The analysis of the results of dalteparin sodium (Fragmin <sup>®</sup>) application for the prevention and treatment of thrombosis of various biodisposi- tion in 62 children has been given. The average relative dose depending on the age of the patient, the effectiveness of application and the <sub>,</sub> <sup>drug s safety; the need to select individually controlled doses has been evaluated.</sup>